TegoScience Inc. (KOSDAQ:191420)
7,180.00
+670.00 (10.29%)
At close: Jun 29, 2026
TegoScience Market Cap
TegoScience has a market cap or net worth of 57.49 billion as of June 29, 2026. Its market cap has decreased by -63.72% in one year.
Market Cap
57.49B
Enterprise Value
25.90B
Revenue
5.83B
Ranking
n/a
PE Ratio
n/a
Stock Price
7,180.00
Market Cap Chart
Since November 6, 2014, TegoScience's market cap has decreased from 110.54B to 57.49B, a decrease of -47.99%. That is a compound annual growth rate of -5.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 29, 2026 | 57.49B | -55.95% |
| Dec 30, 2025 | 130.51B | 30.50% |
| Dec 30, 2024 | 100.00B | -14.80% |
| Dec 28, 2023 | 117.38B | 20.16% |
| Dec 29, 2022 | 97.68B | -43.87% |
| Dec 30, 2021 | 174.03B | -29.20% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| QuadMedicine | 63.27B |
| Naturalendo Tech | 59.45B |
| PanGen Biotech | 58.52B |
| KoBioLabs | 56.90B |
| IMGT Co.,Ltd. | 56.24B |
| EyeGene | 55.33B |
| Progen | 50.12B |
| Psomagen | 46.36B |